STEPAN CO (SCL) Fundamental Analysis & Valuation

NYSE:SCL • US8585861003

Current stock price

50.82 USD
-0.74 (-1.44%)
Last:

This SCL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. SCL Profitability Analysis

1.1 Basic Checks

  • SCL had positive earnings in the past year.
  • SCL had a positive operating cash flow in the past year.
  • Each year in the past 5 years SCL has been profitable.
  • SCL had a positive operating cash flow in each of the past 5 years.
SCL Yearly Net Income VS EBIT VS OCF VS FCFSCL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M

1.2 Ratios

  • SCL has a Return On Assets (1.99%) which is in line with its industry peers.
  • SCL has a Return On Equity of 3.77%. This is comparable to the rest of the industry: SCL outperforms 59.76% of its industry peers.
  • SCL's Return On Invested Capital of 3.29% is in line compared to the rest of the industry. SCL outperforms 47.56% of its industry peers.
  • SCL had an Average Return On Invested Capital over the past 3 years of 3.37%. This is below the industry average of 6.49%.
Industry RankSector Rank
ROA 1.99%
ROE 3.77%
ROIC 3.29%
ROA(3y)1.96%
ROA(5y)3.72%
ROE(3y)3.79%
ROE(5y)7.37%
ROIC(3y)3.37%
ROIC(5y)5.73%
SCL Yearly ROA, ROE, ROICSCL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • SCL has a Profit Margin (2.01%) which is in line with its industry peers.
  • SCL's Profit Margin has declined in the last couple of years.
  • SCL's Operating Margin of 2.95% is on the low side compared to the rest of the industry. SCL is outperformed by 60.98% of its industry peers.
  • In the last couple of years the Operating Margin of SCL has declined.
  • SCL has a worse Gross Margin (11.57%) than 80.49% of its industry peers.
  • In the last couple of years the Gross Margin of SCL has declined.
Industry RankSector Rank
OM 2.95%
PM (TTM) 2.01%
GM 11.57%
OM growth 3Y-26.77%
OM growth 5Y-20.39%
PM growth 3Y-27.63%
PM growth 5Y-21.58%
GM growth 3Y-9.08%
GM growth 5Y-10.82%
SCL Yearly Profit, Operating, Gross MarginsSCL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

3

2. SCL Health Analysis

2.1 Basic Checks

  • SCL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • SCL has more shares outstanding than it did 1 year ago.
  • SCL has more shares outstanding than it did 5 years ago.
  • SCL has a better debt/assets ratio than last year.
SCL Yearly Shares OutstandingSCL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
SCL Yearly Total Debt VS Total AssetsSCL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • An Altman-Z score of 2.58 indicates that SCL is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of SCL (2.58) is better than 69.51% of its industry peers.
  • The Debt to FCF ratio of SCL is 24.70, which is on the high side as it means it would take SCL, 24.70 years of fcf income to pay off all of its debts.
  • SCL's Debt to FCF ratio of 24.70 is in line compared to the rest of the industry. SCL outperforms 42.68% of its industry peers.
  • SCL has a Debt/Equity ratio of 0.27. This is a healthy value indicating a solid balance between debt and equity.
  • SCL has a Debt to Equity ratio of 0.27. This is in the better half of the industry: SCL outperforms 76.83% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 24.7
Altman-Z 2.58
ROIC/WACC0.28
WACC11.62%
SCL Yearly LT Debt VS Equity VS FCFSCL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • SCL has a Current Ratio of 1.29. This is a normal value and indicates that SCL is financially healthy and should not expect problems in meeting its short term obligations.
  • SCL has a worse Current ratio (1.29) than 82.93% of its industry peers.
  • A Quick Ratio of 0.84 indicates that SCL may have some problems paying its short term obligations.
  • SCL's Quick ratio of 0.84 is on the low side compared to the rest of the industry. SCL is outperformed by 71.95% of its industry peers.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 0.84
SCL Yearly Current Assets VS Current LiabilitesSCL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

4

3. SCL Growth Analysis

3.1 Past

  • SCL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -17.27%.
  • Measured over the past years, SCL shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -20.33% on average per year.
  • The Revenue has been growing slightly by 6.96% in the past year.
  • Measured over the past years, SCL shows a small growth in Revenue. The Revenue has been growing by 4.52% on average per year.
EPS 1Y (TTM)-17.27%
EPS 3Y-35.11%
EPS 5Y-20.33%
EPS Q2Q%-116.67%
Revenue 1Y (TTM)6.96%
Revenue growth 3Y-5.61%
Revenue growth 5Y4.52%
Sales Q2Q%5.38%

3.2 Future

  • SCL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 52.12% yearly.
  • SCL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.88% yearly.
EPS Next Y56.77%
EPS Next 2Y52.12%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.81%
Revenue Next 2Y5.04%
Revenue Next 3Y7.13%
Revenue Next 5Y5.88%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SCL Yearly Revenue VS EstimatesSCL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B
SCL Yearly EPS VS EstimatesSCL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

5

4. SCL Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 27.92, SCL can be considered very expensive at the moment.
  • SCL's Price/Earnings ratio is in line with the industry average.
  • The average S&P500 Price/Earnings ratio is at 27.95. SCL is around the same levels.
  • A Price/Forward Earnings ratio of 17.81 indicates a rather expensive valuation of SCL.
  • The rest of the industry has a similar Price/Forward Earnings ratio as SCL.
  • When comparing the Price/Forward Earnings ratio of SCL to the average of the S&P500 Index (38.68), we can say SCL is valued rather cheaply.
Industry RankSector Rank
PE 27.92
Fwd PE 17.81
SCL Price Earnings VS Forward Price EarningsSCL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, SCL is valued a bit cheaper than the industry average as 75.61% of the companies are valued more expensively.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of SCL is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 45.45
EV/EBITDA 8.54
SCL Per share dataSCL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • SCL's earnings are expected to grow with 52.12% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.49
PEG (5Y)N/A
EPS Next 2Y52.12%
EPS Next 3YN/A

6

5. SCL Dividend Analysis

5.1 Amount

  • SCL has a Yearly Dividend Yield of 3.11%. Purely for dividend investing, there may be better candidates out there.
  • SCL's Dividend Yield is rather good when compared to the industry average which is at 2.01. SCL pays more dividend than 81.71% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.81, SCL pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.11%

5.2 History

  • The dividend of SCL is nicely growing with an annual growth rate of 6.58%!
  • SCL has been paying a dividend for at least 10 years, so it has a reliable track record.
  • SCL has decreased its dividend in the last 3 years.
Dividend Growth(5Y)6.58%
Div Incr Years2
Div Non Decr Years2
SCL Yearly Dividends per shareSCL Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • SCL pays out 74.70% of its income as dividend. This is not a sustainable payout ratio.
  • SCL's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP74.7%
EPS Next 2Y52.12%
EPS Next 3YN/A
SCL Yearly Income VS Free CF VS DividendSCL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M -100M
SCL Dividend Payout.SCL Dividend Payout, showing the Payout Ratio.SCL Dividend Payout.PayoutRetained Earnings

SCL Fundamentals: All Metrics, Ratios and Statistics

STEPAN CO

NYSE:SCL (4/21/2026, 3:19:14 PM)

50.82

-0.74 (-1.44%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-23
Earnings (Next)04-28
Inst Owners85.44%
Inst Owner Change0.2%
Ins Owners5.62%
Ins Owner Change6.08%
Market Cap1.15B
Revenue(TTM)2.33B
Net Income(TTM)46.90M
Analysts80
Price Target76.5 (50.53%)
Short Float %1.85%
Short Ratio2.3
Dividend
Industry RankSector Rank
Dividend Yield 3.11%
Yearly Dividend1.55
Dividend Growth(5Y)6.58%
DP74.7%
Div Incr Years2
Div Non Decr Years2
Ex-Date03-02
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-63.87%
Min EPS beat(2)-105.01%
Max EPS beat(2)-22.72%
EPS beat(4)1
Avg EPS beat(4)-34.98%
Min EPS beat(4)-105.01%
Max EPS beat(4)30.63%
EPS beat(8)3
Avg EPS beat(8)-13.56%
EPS beat(12)3
Avg EPS beat(12)-18.06%
EPS beat(16)7
Avg EPS beat(16)-8.2%
Revenue beat(2)0
Avg Revenue beat(2)-2.72%
Min Revenue beat(2)-3.89%
Max Revenue beat(2)-1.55%
Revenue beat(4)1
Avg Revenue beat(4)-0.44%
Min Revenue beat(4)-3.89%
Max Revenue beat(4)5.27%
Revenue beat(8)1
Avg Revenue beat(8)-2.69%
Revenue beat(12)1
Avg Revenue beat(12)-3.81%
Revenue beat(16)5
Avg Revenue beat(16)-1.46%
PT rev (1m)0%
PT rev (3m)-11.76%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-51.65%
EPS NY rev (1m)-14.91%
EPS NY rev (3m)-19.63%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.58%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.08%
Valuation
Industry RankSector Rank
PE 27.92
Fwd PE 17.81
P/S 0.49
P/FCF 45.45
P/OCF 7.8
P/B 0.93
P/tB 1.04
EV/EBITDA 8.54
EPS(TTM)1.82
EY3.58%
EPS(NY)2.85
Fwd EY5.61%
FCF(TTM)1.12
FCFY2.2%
OCF(TTM)6.52
OCFY12.82%
SpS102.78
BVpS54.83
TBVpS49
PEG (NY)0.49
PEG (5Y)N/A
Graham Number47.3829 (-6.76%)
Profitability
Industry RankSector Rank
ROA 1.99%
ROE 3.77%
ROCE 4.07%
ROIC 3.29%
ROICexc 3.57%
ROICexgc 3.9%
OM 2.95%
PM (TTM) 2.01%
GM 11.57%
FCFM 1.09%
ROA(3y)1.96%
ROA(5y)3.72%
ROE(3y)3.79%
ROE(5y)7.37%
ROIC(3y)3.37%
ROIC(5y)5.73%
ROICexc(3y)3.54%
ROICexc(5y)6.25%
ROICexgc(3y)3.87%
ROICexgc(5y)6.93%
ROCE(3y)4.17%
ROCE(5y)7.1%
ROICexgc growth 3Y-30.74%
ROICexgc growth 5Y-23.55%
ROICexc growth 3Y-30.43%
ROICexc growth 5Y-24.07%
OM growth 3Y-26.77%
OM growth 5Y-20.39%
PM growth 3Y-27.63%
PM growth 5Y-21.58%
GM growth 3Y-9.08%
GM growth 5Y-10.82%
F-Score5
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 24.7
Debt/EBITDA 1.75
Cap/Depr 97.2%
Cap/Sales 5.25%
Interest Coverage 2.4
Cash Conversion 75.86%
Profit Quality 54.1%
Current Ratio 1.29
Quick Ratio 0.84
Altman-Z 2.58
F-Score5
WACC11.62%
ROIC/WACC0.28
Cap/Depr(3y)151.26%
Cap/Depr(5y)198.05%
Cap/Sales(3y)7.36%
Cap/Sales(5y)8.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-17.27%
EPS 3Y-35.11%
EPS 5Y-20.33%
EPS Q2Q%-116.67%
EPS Next Y56.77%
EPS Next 2Y52.12%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.96%
Revenue growth 3Y-5.61%
Revenue growth 5Y4.52%
Sales Q2Q%5.38%
Revenue Next Year4.81%
Revenue Next 2Y5.04%
Revenue Next 3Y7.13%
Revenue Next 5Y5.88%
EBIT growth 1Y-2.24%
EBIT growth 3Y-30.88%
EBIT growth 5Y-16.79%
EBIT Next Year173.07%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-35.41%
FCF growth 3YN/A
FCF growth 5Y-25.07%
OCF growth 1Y-8.74%
OCF growth 3Y-2.75%
OCF growth 5Y-8.86%

STEPAN CO / SCL Fundamental Analysis FAQ

What is the fundamental rating for SCL stock?

ChartMill assigns a fundamental rating of 4 / 10 to SCL.


Can you provide the valuation status for STEPAN CO?

ChartMill assigns a valuation rating of 5 / 10 to STEPAN CO (SCL). This can be considered as Fairly Valued.


What is the profitability of SCL stock?

STEPAN CO (SCL) has a profitability rating of 3 / 10.


Can you provide the expected EPS growth for SCL stock?

The Earnings per Share (EPS) of STEPAN CO (SCL) is expected to grow by 56.77% in the next year.


Can you provide the dividend sustainability for SCL stock?

The dividend rating of STEPAN CO (SCL) is 6 / 10 and the dividend payout ratio is 74.7%.